Richmond Pharmacology is excited to attend the 2024 American HeartAssociation (AHA) Scientific Sessions in Philadelphia. This premier event incardiovascular science will bring together global leaders to present anddiscuss the latest innovations in cardiovascular research, prevention, andtreatment. The sessions will cover a wide range of topics, including basic,clinical, and population science.
To connect with our team during the event, please reach out to arrange ameeting.
#Red4Research is a global initiative that recognises the essential role of clinical research in improving treatment, outcomes, and the future of medicine.
Richmond Pharmacology will participate in HFA 2025 in Belgrade from 17–20 May, focusing on heart failure research, clinical trials, and scientific collaboration.
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
.svg){kind=small}
-min.jpg)
.jpg)
